[1]徐 松,豆正莉.NLR、PLR、MLR、SII在结直肠癌诊断中的应用价值[J].医学信息,2024,37(13):85-89.[doi:10.3969/j.issn.1006-1959.2024.13.016]
　Application Value of NLR,PLR,MLR and SII in the Diagnosis of Colorectal Cancer.Application Value of NLR, PLR, MLR and SII in the Diagnosis of Colorectal Cancer[J].Journal of Medical Information,2024,37(13):85-89.[doi:10.3969/j.issn.1006-1959.2024.13.016]
点击复制

NLR、PLR、MLR、SII在结直肠癌诊断中的应用价值()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年13期
页码:
85-89
栏目:
论著
出版日期:
2024-07-01

文章信息/Info

Title:
Application Value of NLR, PLR, MLR and SII in the Diagnosis of Colorectal Cancer
文章编号:
1006-1959（2024）13-0085-05
作者:
徐 松; 豆正莉
（安徽医科大学附属巢湖医院消化内科，安徽 巢湖 238000）
Author(s):
Application Value of NLR;  PLR;  MLR and SII in the Diagnosis of Colorectal Cancer
(Department of Digestive Medicine,Chaohu Hospital of Anhui Medical University,Chaohu 238000,Anhui,China)
关键词:
结直肠恶性肿瘤; 中性粒细胞和淋巴细胞比值; 血小板与淋巴细胞比值; 单核细胞与淋巴细胞比值; 系统炎症指数
Keywords:
Colorectal cancer; Neutrophil-to-lymphocyte ratio; Platelet-to-lymphocyte ratio; Monocyte-to-lymphocyte ratio; Systemic inflammatory index
分类号:
R735.3
DOI:
10.3969/j.issn.1006-1959.2024.13.016
文献标志码:
A
摘要:
目的 探讨中性粒细胞与淋巴细胞比值（NLR）、血小板与淋巴细胞比值（PLR）、单核细胞与淋巴细胞比值（MLR）、系统炎症指数（SII）在结直肠癌的诊断中的应用价值。方法 回顾性分析2021年1月-2023年5月安徽医科大学附属巢湖医院住院的结直肠癌（CRC）、结直肠癌前病变及结直肠息肉患者分别作为CRC组、癌前病变组、息肉组，检测三组NLR、PLR、MLR、SII水平，并分析NLR、PLR、MLR、SII在CRC中的诊断价值。结果 CRC组NLR、PLR、MLR、SII水平均高于癌前病变组及息肉组（P＜0.05）。ROC曲线分析显示，PLR敏感度最高，MLR特异度最高，NLR诊断CRC与非CRC的最佳取值为2.77，ROC曲线下面积为0.638（0.570~0.705），敏感度为51.60%，特异度为76.10%；PLR诊断CRC与非CRC的最佳取值为143.49，ROC曲线下面积为0.648（0.581~0.714），敏感度为57.10%，特异度为70.70%。NLR、PLR、MLR、SII四项指标综合诊断CRC的ROC曲线下面积均大于血清标志物单独及联合应用，且敏感度最高；Logistic回归分析显示，PLR、MLR是预测TNM Ⅰ+Ⅱ期CRC的独立危险因素。结论 NLR、PLR、MLR、SII可提高CRC的检出率，对CRC分期诊断有预测价值。
Abstract:
Objective To investigate the application value of neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR) and systemic inflammatory index (SII) in the diagnosis of colorectal cancer.Methods Patients with colorectal cancer (CRC), colorectal precancerous lesions and colorectal polyps hospitalized in Chaohu Hospital of Anhui Medical University from January 2021 to May 2023 were retrospectively analyzed as CRC group, precancerous lesion group and polyp group. The levels of NLR, PLR, MLR and SII in the three groups were detected, and the diagnostic value of NLR, PLR, MLR and SII in CRC was analyzed.Results The levels of NLR, PLR, MLR and SII in CRC group were higher than those in precancerous lesion group and polyp group (P<0.05). ROC curve analysis showed that PLR had the highest sensitivity and MLR had the highest specificity. The best value of NLR for diagnosing CRC and non-CRC was 2.77, the area under the ROC curve was 0.638 (0.570-0.705), the sensitivity was 51.60%, and the specificity was 76.10%. The optimal value of PLR in the diagnosis of CRC and non-CRC was 143.49, the area under the ROC curve was 0.648 (0.581-0.714), the sensitivity was 57.10%, and the specificity was 70.70%. The area under the ROC curve of NLR, PLR, MLR and SII in the comprehensive diagnosis of CRC was greater than that of serum markers alone and in combination, and the sensitivity was the highest. Logistic regression analysis showed that PLR and MLR were independent risk factors for predicting TNM stage Ⅰ+Ⅱ CRC.Conclusion NLR, PLR, MLR and SII can improve the detection rate of CRC and have predictive value for CRC staging diagnosis.

参考文献/References:

[1]Sung H,Ferlay J,Siegel RL,et al.Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J].CA Cancer J Clin,2021,71(3):209-249.[2]Sinicrope FA.Lynch Syndrome-Associated Colorectal Cancer[J].N Engl J Med,2018,379(8):764-773.[3]Carethers JM,Jung BH.Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer[J].Gastroenterology,2015,149(5):1177-1190.[4]Hamid HKS,Emile SH,Davis GN.Prognostic Significance of Lymphocyte-to-Monocyte and Platelet-to-Lymphocyte Ratio in Rectal Cancer: A Systematic Review,Meta-analysis,and Meta-regression[J].Dis Colon Rectum,2022,65(2):178-187.[5]国家卫生健康委员会医政司,中华医学会肿瘤学分会.中国结直肠癌诊疗规范(2023版)[J].协和医学杂志,2023,14(4):706-733.[6]Hernandez-Ainsa M,Velamazan R,Lanas A,et al.Blood-Cell-Based Inflammatory Markers as a Useful Tool for Early Diagnosis in Colorectal Cancer[J].Front Med (Lausanne),2022,9:843074.[7]Atretkhany KN,Drutskaya MS,Nedospasov SA,et al.Chemokines,cytokines and exosomes help tumors to shape inflammatory microenvironment[J].Pharmacol Ther,2016,168:98-112.[8]Cools-Lartigue J,Spicer J,Mc Donald B,et al.Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis[J].J Clin Invest,2013,123(8):3446-3458.[9]Okugawa Y,Toiyama Y,Yamamoto A,et al.Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer[J].Ann Surg,2020,272(2):342-351.[10]Del Prete M,Giampieri R,Loupakis F,et al.Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: implications for clinical management[J].Oncotarget,2015,6(32):33982-33992.[11]Chen JH,Zhai ET,Yuan YJ,et al.Systemic immune-inflammation index for predicting prognosis of colorectal cancer[J].World J Gastroenterol,2017,23(34):6261-6272.[12]王茜,王一菲,付海龙.术前 NLR、PLR结合 CEA表达水平与结直肠癌 TNM分期相关性分析[J].中国血液流变学杂志,2019,29(4):404-408.[13]唐阳,贾逸文,彭琼.血清和粪便CEA、CA199、AFP辅助诊断结直肠癌的研究[J].分子诊断与治疗杂志,2021,13(10):1665-1668.[14]郭宗全,李艳梅,陈新华.粪便 FCP与血清 CEA联合检测对大肠癌的诊断价值[J].山东医药,2019,59(31):83-85.[15]周婷,吴克俭.中性粒细胞/淋巴细胞、血小板/淋巴细胞和纤维蛋白原在结直肠癌中的预测作用[J].医学研究杂志,2019,48(8):154-157.[16]陈万臣,辛莘,郭雅丽,等.术前外周血NLR、PLR、RDW水平检测对结直肠癌早期诊断的应用价值[J].解放军医药杂志,2022,34(5):15-17.[17]李亚男,熊枝繁,周琦,等.外周血纤维蛋白原、血小板与淋巴细胞比值、癌胚抗原在老年结直肠癌中的预测作用研究[J].临床内科杂志,2022,39(9):602-606.[18]Zhan X,Sun X,Hong Y,et al.Combined Detection of Preoperative Neutrophil-to-Lymphocyte Ratio and CEA as an Independent Prognostic Factor in Nonmetastatic Patients Undergoing Colorectal Cancer Resection Is Superior to NLR or CEA Alone[J].Biomed Res Int,2017,2017:3809464.[19]Bhardwaj M,Weigl K,Tikk K,et al.Multiplex screening of 275 plasma protein biomarkers to identify a signature for early detection of colorectal cancer[J].Mol Oncol,2020,14(1):8-21.[20]Bayo Calero J,Casta?觡o López MA,Casado Monge PG,et al.Analysis of blood markers for early colorectal cancer diagnosis[J].J Gastrointest Oncol,2022,13(5):2259-2268.

更新日期/Last Update: 1900-01-01